I. The rationale for extended-release pharmaceuticals II. Terminology III. Extended-release oral dosage forms IV. Delayed-release oral dosage forms V. USP requirements and FDA Guidance for modified-release dosage forms VI. Clinical considerations in the use of oral modified-release dosage form VII. Packaging and storing modified-release tablets and capsules

I. Factors affecting percutaneous absorption II. Percutaneous absorption enhancer III. Design features of transdermal drug delivery system IV. Percutaneous absorption model V. Advantages and disadvantages of TDDSs VI. Examples of transdermal drug deliver systems VII. General clinical considerations in the use of TDDSs

Part V Firearm and Explosive Injuries Mechanical Injury Part VI Transportation Injuries Mechanical Injury Part VII Craniocerebral Injury

I. Reading skill II. Fast reading III. Structure of the text IV. Important Words V. Detailed study of Text VI. Exercises

I. Reading skill II. Fast reading. III. Structure of the text. IV. Important Words V. Detailed study of Text VI. Exercises

I. Background Information II. Pre-reading Activities III. Text Analysis– Structure IV. Intensive reading V. Writing skill VI. Exercises

I,Background Information II.Pre-reading Activities TII.Text Analysis-Structure IV.Intensive reading V.Writing skill VI.Exercises

I.Background Information ll.Pre-reading Activities lll.Text Analysis-Structure IV.Intensive reading V.Writing skill VI.Exercises

I.Background Information II.Pre-reading Activities III.Text Analysis-Structure IV.Intensive Reading V.Writing Skill VI.Exercises

I. Reading skill II. Fast reading. III. Structure of the text. IV. Important Words V. Detailed study of Text VI. Exercises